3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
23
Rectal Neoplasms
11
Colonic Neoplasms
11
Pancreatic Neoplasms
9
Stomach Neoplasms
8
Esophageal Neoplasms
8
Adenocarcinoma Of Esophagus
8
Cholangiocarcinoma
6
Adenocarcinoma
6
Neoplasm Metastasis
5
Lymphoma, Large B-Cell, Diffuse
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Ovarian Neoplasms
3
Neoplasms
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Biliary Tract Neoplasms
3
Recurrence
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Small Bowel Adenocarcinoma
1
Interventions
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
Oxaliplatin
×
30 days
×
Clear all
No trials found.